Btg Pactual Global Asset Management LTD Ionis Pharmaceuticals Inc Transaction History

Btg Pactual Global Asset Management LTD

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 14, 2019	SELL	$43.37 - $59.54 $431,054 - $591,768	-9,939 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$42.88 - $53.7 $855,841 - $1.07 Million	-19,959 Reduced 66.76%	9,939 $513,000
Q2 2018 Aug 14, 2018	BUY	$40.53 - $50.7 $50,095 - $62,665	1,236 Added 4.31%	29,898 $1.25 Million
Q1 2018 May 15, 2018	BUY	$44.08 - $55.05 $151,370 - $189,041	3,434 Added 13.61%	28,662 $1.26 Million
Q4 2017 Feb 14, 2018	BUY	$50.3 - $64.39 $42,905 - $54,924	853 Added 3.5%	25,228 $1.27 Million
Q3 2017 Nov 14, 2017	SELL	$45.56 - $59.57 $46,152 - $60,344	-1,013 Reduced 3.99%	24,375 $1.24 Million
Q2 2017 Aug 14, 2017	BUY	N/A	25,388	25,388 $1.29 Million

389

125M

2.25M

510K

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $5.64B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

Get notified when there are updates to the investment portfolio of Btg Pactual Global Asset Management LTD, based on Form 13F filings with the SEC.

Stay updated on Btg Pactual Global Asset Management LTD with notifications on news.